Accelerated Progression to Type 1 Diabetes in the Presence of and Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct and Autoantibody Risk Profiles.

Objective: We investigated the effect of HLA class I risk alleles on disease progression in various phases of subclinical islet autoimmunity in first-degree relatives of patients with type 1 diabetes.

Research Design And Methods: A registry-based group of siblings/offspring (aged 0-39 years) was monitored from single- to multiple-autoantibody positivity ( = 267) and from multiple-autoantibody positivity to clinical onset ( = 252) according to , , , and status. Genetic markers were determined by PCR sequence-specific oligotyping.